United States · 
What does Merck Global Health Innovation Fund invest in?
Merck Global Health Innovation Fund invests most often at Series B and Venture (56% of the rounds on record), in sectors such as Mental Health, E-health and Ehealth.
Merck Global Health Innovation Fund highlights
- 01
2 cheques in the last 12 months
- 02
Mostly Series B and Venture: 56% of its rounds
- 03
Sole investor in 10 rounds, median $12M
- 04
1 exits from the portfolio
What they do
Sustainability overview Philanthropy Merck Medical Outreach Program Impact Venture FundFrom their own website
- Type
- Corporate VC (from a list, unverified)
- Cheque size
- $150K – $150K as they say
- Stages
- Pre-seedSeedSeries ASeries BGrowthPre-IPO
- Sectors
- Mental HealthE-healthEhealth
- Based in
- Newark, United States
- Cold pitches
- Not accepted
The record
Every round we can evidence, newest first53 appearances
- 2026
2 rounds
- Oct
- Mar
- 2025
1 round
- Feb
- 2024
1 round
- May
- 2023
2 rounds
- Aug
- May
- 2020
1 round
- Sept
- 2019
3 rounds
- Nov
- Jul
- Mar
- 2018
2 rounds
- May
- May
- 2017
6 rounds
- Dec
- Nov
- Sept
- Jun
- Apr
- Mar
- 2015
10 rounds
- Oct
- Oct
- Aug
- Jul
- Jul
- May
- Apr
- Mar
- Mar
- Feb
- 2014
8 rounds
- Oct
- Oct
- Sept
- Aug
- Jun
- May
- Apr
- Jan
- 2013
8 rounds
- Dec
- Sept
- Sept
- Jun
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
We hold 14 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What they claim to have backed
From their own portfolio page (on their website)
8 of 60 we have independently watched raise
AltislabsAndsonbiotechEssentialaccessibilityGesundPerceivResyncStempharmZafrens9bioAccessibilityApertureAscentbioAugmentbiologicsBrainifyCelinebioDannceDeepforestsciDeepseqDropgenieDsrE9genomicsEpiloidEsyalabsExternaFind a trialFletcherbioFocaiForecastHealth Plan -HebbianbioImyooInaedisInterobiosystemsJuraMagnalabsMerck Access ProgramMerck ManualsMerck for MothersMerckHelpsMisochipModernvivoModularitNanofacileNeigesbiotechNetriNinediagnosticsNuvobioOncOrbits-oncologyOrbtxPcareProvidentia-technologiesReadysetpotatoRimetherapeuticsSerinusSimmunomeStereobioSupplier help for AribaSupplier registrationSynthexlabsand 4 more
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.
Exits from the portfolio
Companies it backed that were later bought or listed1 in all
An exit counts when it came after the firm's first round in the company. From historical deal records.